These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6169615

  • 1. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB.
    Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
    [No Abstract] [Full Text] [Related]

  • 2. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 3. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC.
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [Abstract] [Full Text] [Related]

  • 4. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A, Weller IV, Bassendine MF, Fowler MJ, Monjardino J, Thomas HC, Sherlock S.
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [Abstract] [Full Text] [Related]

  • 5. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
    Romeo F, Russo A, Liuzzo P.
    Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S, Saito S, Yoshikawa A, Shibayama T, Kamimura T, Suzuki S, Ischida F.
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [Abstract] [Full Text] [Related]

  • 7. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI, Kitchen LW, Scullard GH, Robinson WS, Gregory PB, Merigan TC.
    JAMA; 1982 Apr 23; 247(16):2261-5. PubMed ID: 6175774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
    Yokosuka O, Omata M, Imazeki F, Hirota K, Mori J, Uchiumi K, Ito Y, Okuda K.
    Gastroenterology; 1985 Aug 23; 89(2):246-51. PubMed ID: 4007415
    [Abstract] [Full Text] [Related]

  • 10. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M, Uchiumi K.
    J Hepatol; 1986 Aug 23; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
    Liaw YF, Lin DY, Chen TJ, Chu CM, Sheen IS.
    Infection; 1984 Aug 23; 12(4):248-50. PubMed ID: 6490167
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
    Hafkin B, Pollard RB, Tiku ML, Robinson WS, Merigan TC.
    Antimicrob Agents Chemother; 1979 Dec 23; 16(6):781-7. PubMed ID: 533259
    [Abstract] [Full Text] [Related]

  • 13. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
    Guerre J, Gaudric M, Couturier D, Levy C.
    Presse Med; 1983 Mar 19; 12(12):743-6. PubMed ID: 6220311
    [Abstract] [Full Text] [Related]

  • 14. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
    Chadwick RG, Bassendine MF, Crawford EM, Thomas HC, Sherlock S.
    Br Med J; 1978 Aug 19; 2(6136):531-3. PubMed ID: 698557
    [Abstract] [Full Text] [Related]

  • 15. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K, Abb J, Farack UM, Wiebecke B.
    Hepatogastroenterology; 1985 Aug 19; 32(4):178-80. PubMed ID: 2865200
    [Abstract] [Full Text] [Related]

  • 16. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug 19; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S, Thomas HC.
    Lancet; 1985 Dec 14; 2(8468):1343-6. PubMed ID: 2866396
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV, Bassendine MF, Craxi A, Fowler MJ, Monjardino J, Thomas HC, Sherlock S.
    Gut; 1982 Sep 14; 23(9):717-23. PubMed ID: 6179819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.